Obesity and metabolic syndrome: Clinical sciences

00:00 / 00:00

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

of complete

A 42-year-old woman comes to the primary care clinic to discuss treatment options for obesity. She has lost 3% of her body weight over the past six months with dietary counseling, a commercial weight loss program, and exercise. Medical history is significant for diarrhea-predominant irritable bowel syndrome, seizure disorder, and insomnia. Her current medications include loperamide, levetiracetam, and melatonin. Family history is significant for multiple endocrine neoplasia type 2 in her mother, and the patient has refused genetic testing for MEN2 in the past. Vital signs are within normal limits. BMI is 38 kg/m2. Physical examination is noncontributory. Which of the following medications is most appropriate for weight loss management in this patient?  

Transcript

Watch video only

Obesity is a condition characterized by excessive fat accumulation in the body, and is strongly associated with the development of other conditions, such as type 2 diabetes mellitus, dyslipidemia, cardiovascular disease, and even malignancy. Multiple factors contribute to the development of obesity, including genetics, western diet, sedentary lifestyle, inadequate sleep, and certain medication side effects.

Body fat, also known as adipose tissue, secretes adipokines, which can lead to widespread systemic inflammation and insulin resistance. Based on the body mass index, or BMI for short, individuals with obesity can be categorized into 4 main groups that include overweight, class I obesity, class II obesity, and class III obesity.

Now, if you suspect obesity, first you should obtain a focused history and physical. History may reveal symptoms like joint pain, snoring, fatigue, and dyspnea, as well as mood symptoms, such as depression. Additionally, the patient might present with obesity-related comorbidities, such as metabolic syndrome, diabetes mellitus, hypertension, and dyslipidemia. On the other hand, physical exam will reveal excess adipose tissue and larger waist circumference, and some patients may also have abdominal striae, acanthosis nigricans, and lower extremity edema.

Okay, the next step is to calculate the BMI using the patient’s weight in kilograms and height in meters. If the BMI is 25 to 29.9, the patient is overweight; if the BMI is between 30 and 34.9, the patient falls under class I obesity; between 35 and 39.9 is class II obesity; and finally, a BMI greater than or equal to 40 is class III obesity.

Here’s a clinical pearl for you! Though the diagnosis of obesity hinges on BMI, keep in mind that it's an imperfect individual measure. In fact, certain racial and ethnic groups, such as those with ancestry from some parts of Asia, may experience complications of obesity at lower BMIs, while others with higher BMIs but low adiposity have a lower risk of these complications.

Now, patients who are overweight or class I obesity get the same approach. In both groups, your next step is to assess for obesity-related comorbidities like hypertension, obstructive sleep apnea or OSA, non-alcoholic fatty liver disease or NAFLD, and dyslipidemia, as well as prediabetes and type 2 diabetes mellitus.

Sources

  1. "A review of current guidelines for the treatment of obesity" Am J Manag Care (2022)
  2. "Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement" JAMA (2021)
  3. "Screening for Obstructive Sleep Apnea" JAMA (2022)
  4. "A comprehensive definition for metabolic syndrome" Dis Model Mech (2009 )
  5. "Current treatments for obesity" Clin Med (Lond) (2019 )
  6. "Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic" Gastroenterol Hepatol (NY) (2019 )
Elsevier

Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX